- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1663
Publisher
MDPI AG
Online
2020-06-24
DOI
10.3390/cancers12061663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New landscapes and horizons in hepatocellular carcinoma therapy
- (2020) Melchiorre Cervello et al. Aging-US
- Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
- (2020) Siqi Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intake
- (2020) Hai le Ba et al. PHARMACOGENOMICS
- Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
- (2020) Luca Faloppi et al. Targeted Oncology
- Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
- (2020) Manali Dimri et al. Cancers
- Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma
- (2020) Lei Fan et al. MOLECULAR CANCER THERAPEUTICS
- HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma
- (2020) Yang Shi et al. OncoTargets and Therapy
- LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma
- (2020) Xiaofeng Tang et al. Biomed Research International
- Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
- (2019) Bo Hyun Kim et al. Gut and Liver
- Goals and targets for personalized therapy for HCC
- (2019) Thomas Couri et al. Hepatology International
- Systemic Treatment for Advanced Hepatocellular Carcinoma
- (2019) Mohamed Bouattour et al. Liver Cancer
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
- (2019) Ying Zhu et al. GUT
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- Epigenetic Regulation of UDP-Glucuronosyltransferase by microRNA-200a/-183: Implications for Responses to Sorafenib Treatment in Patients with Hepatocellular Carcinoma
- (2019) Yang Ge et al. CANCER LETTERS
- Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response
- (2019) Stefano Caruso et al. GASTROENTEROLOGY
- Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
- (2019) Dai-Min Xiang et al. GUT
- The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
- (2019) Jacopo Baglieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
- (2019) Weidong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy
- (2019) Qing Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway
- (2019) Shida Yang et al. CANCER GENE THERAPY
- Sorafenib activity and disposition in liver cancer does not depend on organic cation transporter 1 ( OCT 1)
- (2019) Mingqing Chen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib
- (2019) Xie Weng et al. OncoTargets and Therapy
- Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer
- (2019) Tomoko Ozeki et al. Scientific Reports
- A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- (2019) R.K. Kelley et al. Clinical and Translational Gastroenterology
- Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
- (2019) Tao Yan et al. Cancer Cell International
- Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
- (2019) Xiaofan Ding et al. GASTROENTEROLOGY
- Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
- (2019) Antje Garten et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA NEAT1 promotes autophagy via regulating miR‐204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma
- (2019) Xinyu Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Activation of EGFR‐KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma
- (2019) Lijun Pang et al. MOLECULAR CARCINOGENESIS
- Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
- (2019) Elena De Mattia et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression
- (2019) Tommaso Mello et al. INTERNATIONAL JOURNAL OF CANCER
- Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma
- (2019) Arndt Vogel et al. CANCER TREATMENT REVIEWS
- Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
- (2018) Debanjan Dhar et al. CANCER CELL
- Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
- (2018) Hongping Zheng et al. HEPATOLOGY
- New therapeutic strategies to treat human cancers expressing mutant p53 proteins
- (2018) Giovanni Blandino et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
- (2018) Man Tong et al. JOURNAL OF HEPATOLOGY
- Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma
- (2018) Chaobo Hu et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma
- (2018) Wei-Ping Zhu et al. Cell Death & Disease
- CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
- (2018) Shuai Lu et al. Cell Death & Disease
- Molecular bases of the poor response of liver cancer to chemotherapy
- (2018) Jose J.G. Marin et al. Clinics and Research in Hepatology and Gastroenterology
- Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
- (2018) Anna Tutusaus et al. Oncotarget
- Cirrhotic stiffness affects the migration of hepatocellular carcinoma cells and induces sorafenib resistance through YAP
- (2018) Jian Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Role of MicroRNAs in Hepatocellular Carcinoma
- (2018) Xin Xu et al. Journal of Cancer
- 59PDFinal analysis of serum biomarkers in patients (pts) from the phase III study of lenvatinib (LEN) vs sorafenib (SOR) in unresectable hepatocellular carcinoma (uHCC) [REFLECT]
- (2018) R S Finn et al. ANNALS OF ONCOLOGY
- Epigenetic events involved in OCT1-dependent impaired response of hepatocellular carcinoma to sorafenib
- (2018) Ruba Al-Abdulla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Recent progress in the emerging role of exosome in hepatocellular carcinoma
- (2018) Mubalake Abudoureyimu et al. CELL PROLIFERATION
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion (ADME genes) in Hepatocellular Carcinoma
- (2018) Dong Gui Hu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Non-redundant functions of EMT transcription factors
- (2018) Marc P. Stemmler et al. NATURE CELL BIOLOGY
- Wnt–β-catenin signalling in liver development, health and disease
- (2018) Maria J. Perugorria et al. Nature Reviews Gastroenterology & Hepatology
- Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies
- (2018) Yao Xiong et al. PLoS One
- TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
- (2018) Wenliang Tan et al. EBioMedicine
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- Mechanisms of DNA damage, repair, and mutagenesis
- (2017) Nimrat Chatterjee et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regorafenib as treatment for patients with advanced hepatocellular cancer
- (2017) Kiruthikah Thillai et al. Future Oncology
- Hepatocyte autotaxin expression promotes liver fibrosis and cancer
- (2017) Eleanna Kaffe et al. HEPATOLOGY
- FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
- (2017) Lixia Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma
- (2017) Lu Hua et al. PATHOLOGY RESEARCH AND PRACTICE
- Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1
- (2017) Hiroyoshi Koide et al. XENOBIOTICA
- The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
- (2017) Yanhong Xiao et al. Analytical Cellular Pathology
- Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1
- (2017) Yusuke Okano et al. Oncology Letters
- Prognostic significance of XRCC4 expression in hepatocellular carcinoma
- (2017) Jun Lu et al. Oncotarget
- The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
- (2017) Andreas Geier et al. Oncotarget
- Hypoxia inducible factors in hepatocellular carcinoma
- (2017) Chu Chen et al. Oncotarget
- Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
- (2017) Mariko Yoshida et al. Scientific Reports
- Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma
- (2017) Yuelong Liang et al. Cancer Medicine
- NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism
- (2016) Chia-Lin Chen et al. Cell Metabolism
- The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice
- (2016) Selvi Durmus et al. DRUG RESISTANCE UPDATES
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Roles ofXRCC1/XPD/ERCC1Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization
- (2016) Xu-Cai Wang et al. Genetic Testing and Molecular Biomarkers
- Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination
- (2016) Amalia Azzariti et al. HEPATOLOGY
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
- (2016) Zhen Qu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- Regorafenib induced severe toxic hepatitis: characterization and discussion
- (2016) Anne Sacré et al. LIVER INTERNATIONAL
- TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells
- (2016) Nathan Ungerleider et al. MOLECULAR CARCINOGENESIS
- Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity
- (2016) Sander Bins et al. PHARMACOGENOMICS
- MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
- (2016) Tetsu Tomonari et al. Oncotarget
- Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update
- (2016) Masatoshi Kudo Liver Cancer
- Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids
- (2016) Yeonhwa Song et al. Scientific Reports
- Regorafenib Is Transported by the Organic Anion Transporter 1B1 and the Multidrug Resistance Protein 2
- (2015) Hiroki Ohya et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- High Serum Transforming Growth Factor- 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
- (2015) T.-H. Lin et al. CLINICAL CANCER RESEARCH
- Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
- (2015) T. Kawai et al. CLINICAL CANCER RESEARCH
- Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade
- (2015) Dong-Xian Guan et al. HEPATOLOGY
- MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
- (2015) Jun-Nian Zhou et al. HEPATOLOGY
- Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options
- (2015) Celina Ang et al. JOURNAL OF SURGICAL ONCOLOGY
- Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
- (2015) Francesca V. Negri et al. LIVER INTERNATIONAL
- Molecular basis for DNA strand displacement by NHEJ repair polymerases
- (2015) Edward J. Bartlett et al. NUCLEIC ACIDS RESEARCH
- Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)
- (2015) Anita Kort et al. PHARMACEUTICAL RESEARCH
- Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma
- (2015) FENG LIU et al. Oncology Letters
- Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
- (2015) Wei-Ching Chen et al. Oncotarget
- Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
- (2015) Xian-Peng Li et al. Oncotarget
- Sorafenib inhibits cancer side population cells by targeting c-Jun N-terminal kinase signaling
- (2015) JONG BIN KIM et al. Molecular Medicine Reports
- Reptin Regulates DNA Double Strand Breaks Repair in Human Hepatocellular Carcinoma
- (2015) Anne-Aurélie Raymond et al. PLoS One
- Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
- (2015) Catia Giovannini et al. Oncotarget
- Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET
- (2014) Q. Xiang et al. CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults
- (2014) Robert C. Shumaker et al. CLINICAL DRUG INVESTIGATION
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
- (2014) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
- (2014) Joan Fernando et al. INTERNATIONAL JOURNAL OF CANCER
- Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein
- (2014) Qing-feng Xiang et al. LIVER INTERNATIONAL
- The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib
- (2014) You-Bing Zheng et al. MEDICAL ONCOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma
- (2014) HAIYONG WANG et al. ONCOLOGY REPORTS
- BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
- (2014) Wei-Chien Huang et al. PLoS One
- Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
- (2014) Ling Ye et al. PLoS One
- Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
- (2014) R Sonntag et al. Cell Death & Disease
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
- (2014) E. Horwitz et al. Cancer Discovery
- Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma
- (2014) Sheau-Fang Yang et al. Biomed Research International
- Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
- (2014) Kenji Takahashi et al. FEBS Open Bio
- The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
- (2013) Jose JG Marin et al. ACTA PHARMACOLOGICA SINICA
- Association of XPD and XRCC1 Genetic Polymorphisms with Hepatocellular Carcinoma Risk
- (2013) Lian-Yi Guo et al. Asian Pacific Journal of Cancer Prevention
- Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
- (2013) E. I. Zimmerman et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
- (2013) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
- (2013) Olivier Govaere et al. GUT
- Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
- (2013) Elisa Herraez et al. HEPATOLOGY
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model
- (2013) Yanping Cun et al. PLoS One
- The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
- (2013) Ariel Ka-Man Chow et al. PLoS One
- Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment
- (2013) Yuanyuan Zhao et al. OncoTargets and Therapy
- Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling
- (2012) Shun Fujimaki et al. CANCER LETTERS
- Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
- (2012) C. J. Peer et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
- (2012) C Dudgeon et al. ONCOGENE
- Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study
- (2012) Pascaline Boudou-Rouquette et al. PLoS One
- The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
- (2012) Daria Capece et al. Biomed Research International
- Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib
- (2011) Yoshihiko Shibayama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
- (2011) Joan Fernando et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
- (2011) T. Nagai et al. MOLECULAR CANCER THERAPEUTICS
- Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
- (2010) Shigeru Ueda et al. ANNALS OF SURGICAL ONCOLOGY
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Association of TP53 Mutations With Stem Cell-Like Gene Expression and Survival of Patients With Hepatocellular Carcinoma
- (2010) Hyun Goo Woo et al. GASTROENTEROLOGY
- Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway
- (2010) Xiao Qi Wang et al. HEPATOLOGY
- The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
- (2010) S. Agarwal et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence
- (2009) Gudrun Zulehner et al. AMERICAN JOURNAL OF PATHOLOGY
- Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters
- (2009) S. Hu et al. CLINICAL CANCER RESEARCH
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- Epithelial–mesenchymal transition in hepatocellular carcinoma
- (2009) Franziska van Zijl et al. Future Oncology
- Cancer stem/progenitor cells are highly enriched in CD133+CD44+population in hepatocellular carcinoma
- (2009) Zheng Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains
- (2009) G. Bellot et al. MOLECULAR AND CELLULAR BIOLOGY
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Identification of local and circulating cancer stem cells in human liver cancer
- (2008) Zhen Fan Yang et al. HEPATOLOGY
- Liver stem cells and hepatocellular carcinoma
- (2008) Lopa Mishra et al. HEPATOLOGY
- Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity
- (2008) Audrey Sermeus et al. Molecular Cancer
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Progenitor/stem cells give rise to liver cancer due to aberrant TGF- and IL-6 signaling
- (2008) Y. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started